Ixekizumab reduces key IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R-MedSci.cn

Ixekizumab reduces key IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R

Gudjonsson, J; Tsoi, LC; Blauvelt, A; Papp, KA; Dow, ER; Gemperline, DC; Elmaraghy, H; Krishnan, V

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023; 143 (5): S100

科室
- - 订阅+
  - 更多科室
工具
服务